Showing results (21-30 of 240) with videos related to
Sort By:
Pageof 24
Cancer Letters|December 4, 2003
Farnesyl-O-acetylhydroquinone and geranyl-O-acetylhydroquinone suppress the proliferation of murine B16 melanoma cells, human prostate and colon adenocarcinoma cells, human lung carcinoma cells, and human leukemia cellsJennifer A McAnally, Manfred Jung, Huanbiao MoCurrent Opinion in Chemical Biology|March 27, 2018
Epigenetic small molecule modulators of histone and DNA methylationAlexander-Thomas Hauser, Dina Robaa, Manfred JungCurrent Topics in Medicinal Chemistry|April 10, 2009
Assays for histone deacetylasesAlexander-Thomas Hauser, Mira Jung, Manfred JungCurrent Pharmaceutical Design|March 14, 2008
Inhibitors of NAD+ dependent histone deacetylases (sirtuins)Robert C Neugebauer, Wolfgang Sippl, Manfred JungActa Crystallographica. Section F, Structural Biology Communications|December 2, 2015
Seeding for sirtuins: microseed matrix seeding to obtain crystals of human Sirt3 and Sirt2 suitable for soakingTobias Rumpf, Stefan Gerhardt, Oliver Einsle, et al.Epigenetics|November 16, 2016
Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectivesInsa Schiffmann, Gabriele Greve, Manfred Jung, et al.Radiation Research|May 27, 2004
Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitorsYin Zhang, Manfred Jung, Anatoly Dritschilo, et al.Chemmedchem|January 23, 2014
Mind the methyl: methyllysine binding proteins in epigenetic regulationTobias Wagner, Dina Robaa, Wolfgang Sippl, et al.Medicinal Research Reviews|October 14, 2009
NAD(+) -dependent histone deacetylases (sirtuins) as novel therapeutic targetsJörg Schemies, Urszula Uciechowska, Wolfgang Sippl, et al.Chembiochem : a European Journal of Chemical Biology|November 7, 2019
Validation of the Slow Off-Kinetics of Sirtuin-Rearranging Ligands (SirReals) by Means of Label-Free Electrically Switchable Nanolever TechnologyMatthias Schiedel, Herwin Daub, Aymelt Itzen, et al.Pageof 24